Treatment of cutaneous lupus with topical ruxolitinib cream

Jonathan J Park; Alicia J Little; Matthew D Vesely

doi:10.1016/j.jdcr.2022.08.038

Treatment of cutaneous lupus with topical ruxolitinib cream

JAAD Case Rep. 2022 Aug 28:28:133-135. doi: 10.1016/j.jdcr.2022.08.038. eCollection 2022 Oct.

Authors

Jonathan J Park^{1

2}, Alicia J Little², Matthew D Vesely²

Affiliations

¹ Department of Genetics, Yale University School of Medicine, New Haven, Connecticut.
² Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.

No abstract available

Keywords: AI, antibody index; CLE; CLE, cutaneous lupus erythematosus; DLE; DLE, discoid lupus erythematosus; JAK; SLE; SLE, systemic lupus erythematosus; cutaneous lupus; discoid lupus; lupus; ruxolitinib; topical.

Publication types

Case Reports

Grants and funding

UL1 TR001863/TR/NCATS NIH HHS/United States